InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Slonin Jonathan, Directeur Clinique. Insider active across 1 company, notably Pacira BioSciences, Inc.. In total, 21 reports have been recorded. Split: 0 buy · 8 sells. Total volume traded: €447k. Activity tracked since 3 August 2021. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Slonin Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
3,040 股@ US$23.230.0076% mcap6.7% 占其流量Common StockSEC:0001628280-26-057759:0
3,261 股@ US$22.8210.9% 占其流量Common StockSEC:0001628280-26-019891:0
54,546 股0Common StockSEC:0001628280-26-008075:0
6,168 股@ US$20.5413.4% 占其流量Common StockSEC:0001628280-26-005155:0
381 股@ US$24.461.0% 占其流量Common StockSEC:0001628280-26-000968:0
3,960 股@ US$24.0912.1% 占其流量Common StockSEC:0001628280-25-053205:0
315 股@ US$22.071.1% 占其流量Common StockSEC:0001396814-25-000095:0
5,084 股@ US$26.4022.5% 占其流量Common StockSEC:0001396814-25-000067:0
93,600 股0Common StockSEC:0001396814-25-000033:0
371 股@ US$18.331.6% 占其流量Common StockSEC:0001396814-25-000007:0
305 股@ US$20.751.4% 占其流量Common StockSEC:0001396814-24-000100:0
437.271 股@ US$24.3192.4% 占其流量Common StockSEC:0001396814-24-000088:0
5,012 股@ US$28.5732.9% 占其流量Common StockSEC:0001396814-24-000084:0
1,615 股@ US$30.8911.3% 占其流量Common StockSEC:0001396814-24-000051:0
5,000 股0Common StockSEC:0001396814-24-000013:0
471 股@ US$38.9914.2% 占其流量Common StockSEC:0001209191-23-035263:0
308 股@ US$55.704.2% 占其流量Common StockSEC:0001209191-22-044554:0
924 股@ US$57.18812.7% 占其流量Common StockSEC:0001209191-22-041521:0
362 股@ US$61.3742.6% 占其流量Common StockSEC:0001209191-22-035232:0
2,000 股@ US$52.3712.4% 占其流量Common StockSEC:0001209191-22-031854:0
5,000 股0Common StockSEC:0001209191-21-049940:0
21 条申报中的 21 条
About Slonin Jonathan
SLONIN JONATHAN is Directeur Clinique. He is also Chief Medical Officer at Pacira BioSciences, Inc. (XNAS). The 20 filings on record concern, for the recent sample of 20 filings, disposals, with EUR 0 of purchases and EUR 386515 of sales between 2021-08-05 and 2026-03-19.
